Asthma  >>  Breztri Aerosphere (budesonide/formoterol fumarate/glycopyrronium)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Breztri Aerosphere (budesonide/formoterol fumarate/glycopyrronium) / AstraZeneca
KALOS, NCT04609878 / 2020-001520-34: Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma

Recruiting
3
2200
Europe, Canada, Japan, US, RoW
BGF MDI 320/28.8/9.6 μg, BGF, BGF MDI 320/14.4/9.6 μg, BFF MDI 320/9.6 μg, BFF, BFF pMDI 320/9 μg, Symbicort®
AstraZeneca
Asthma
03/25
03/25
LOGOS, NCT04609904 / 2020-001521-31: Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma

Recruiting
3
2200
Europe, US, RoW
BGF MDI 320/28.8/9.6 μg, BGF, BGF MDI 320/14.4/9.6 μg, BFF MDI 320/9.6 μg, BFF, BFF pMDI 320/9 μg, Symbicort®
AstraZeneca
Asthma
03/25
03/25

Download Options